Mapra Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 24-10-2024
- Paid Up Capital ₹ 1.50 M
as on 24-10-2024
- Company Age 39 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.05 Cr
as on 24-10-2024
- Revenue -7.05%
(FY 2023)
- Profit -21.11%
(FY 2023)
- Ebitda -18.28%
(FY 2023)
- Net Worth 11.46%
(FY 2023)
- Total Assets 3.21%
(FY 2023)
About Mapra Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹4.05 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Randhir Bachan and Mukesh Kumar serve as directors at the Company.
- CIN/LLPIN
U24100MH1985PTC037946
- Company No.
037946
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Nov 1985
- Date of AGM
14 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mapra Laboratories Pvt Ltd offer?
Mapra Laboratories Pvt Ltd offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Cardiovascular Drugs & Medication, Antidiabetic Medicine, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Immunosuppressive Drugs, Osteoporosis Medications.
Who are the key members and board of directors at Mapra Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Randhir Bachan  | Director | 07-Jan-2000 | Current |
| Mukesh Kumar | Director | 02-Aug-2018 | Current |
Financial Performance of Mapra Laboratories.
Mapra Laboratories Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.05% decrease. The company also saw a substantial fall in profitability, with a 21.11% decrease in profit. The company's net worth Soared by an impressive increase of 11.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mapra Laboratories?
In 2023, Mapra Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 26 May 1993 | ₹1.70 Cr | Satisfied |
State Bank Of India Creation Date: 22 Nov 1988 | ₹2.35 Cr | Satisfied |
How Many Employees Work at Mapra Laboratories?
Mapra Laboratories has a workforce of 654 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mapra Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mapra Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
